Archives
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Berberine (CAS 2086-83-1): Advanced Insights into AMPK Ac...
2025-10-19
Explore the multifaceted role of Berberine, an isoquinoline alkaloid and potent AMPK activator, in metabolic and inflammation research. This in-depth analysis uncovers novel mechanisms linking LDL receptor upregulation, inflammasome attenuation, and translational applications that differentiate Berberine’s utility in modern biomedical research.
-
Berberine (CAS 2086-83-1): Precision Modulation of Metabo...
2025-10-18
Explore the advanced mechanistic roles of berberine, an isoquinoline alkaloid and AMPK activator for metabolic regulation, with fresh insights into LDL receptor upregulation and inflammasome crosstalk. This article uniquely integrates translational data and emerging research applications beyond standard metabolic and inflammation studies.
-
Pemetrexed: Applied Antifolate Antimetabolite Strategies ...
2025-10-17
Leverage Pemetrexed’s multi-targeted antifolate mechanism to disrupt nucleotide biosynthesis and probe DNA repair vulnerabilities in advanced tumor models. This article delivers actionable experimental workflows, troubleshooting insights, and comparative advantages for researchers aiming to optimize cancer chemotherapy strategies beyond standard protocols.
-
Pemetrexed in Translational Oncology: Mechanistic Foresig...
2025-10-16
This thought-leadership article offers an authoritative synthesis of Pemetrexed’s multifaceted antifolate antimetabolite mechanisms, with actionable insights for translational oncology teams. Leveraging recent advances in DNA repair profiling and experimental models, we chart a roadmap for integrating Pemetrexed into precision chemotherapeutic strategies—moving well beyond standard product pages to inform research design, combination therapies, and the future of cancer biology.
-
Pemetrexed in Translational Oncology: Mechanistic Leverag...
2025-10-15
Explore the multifaceted role of pemetrexed (LY-231514) as a multi-targeted antifolate antimetabolite disrupting nucleotide biosynthesis in cancer chemotherapy research. This thought-leadership article synthesizes advanced mechanistic insight, critical gene expression findings, and strategic considerations for translational researchers. By contextualizing pemetrexed’s action within the framework of DNA repair vulnerabilities—such as BRCAness and homologous recombination defects—and integrating emerging data on immune modulation, we offer actionable guidance for designing robust experimental models and advancing therapeutic innovation. Distinct from standard product pages, this article critically evaluates the competitive landscape, builds on recent literature, and outlines visionary opportunities for deploying pemetrexed in synergistic, next-generation oncology paradigms.
-
br Rho family GTPases are molecular
2022-03-01

Rho-family GTPases are molecular switches; most which cycle from an ‘on’ GTP bound state to an ‘off’ GDP bound state, driven by GEFs (guanine nucleotide exchange factors) and GAPs (GTPase-activating proteins) respectively. Association with lipid membranes through a lipid (farnesyl or geranylgerany
-
GSTP catalyzed reduction of Prdx enhances
2022-03-01

GSTP1-1 catalyzed reduction of Prdx6 enhances its peroxidase activity. Using standard NADPH/GR/GSH-coupled assays we used cell lysates from the transiently transfected Bazedoxifene HCl receptor to measure the influence of GSTP1 allelic variation on peroxidase activity. Specificity for detection of
-
br Acknowledgements Support provided by
2022-03-01

Acknowledgements Support provided by projects PTDC/SAU-MIC/115178/2009 and PEst-OE/QUI/UI0612/2011 from the Fundação para a Ciência e a Tecnologia, Portugal. Diabetes Mellitus Diabetes mellitus is a chronic, multisystem metabolic disorder caused by a combination of environmental and genetic f
-
Glucose uptake a critical metabolic control point in
2022-02-28

Glucose uptake, a critical metabolic control point in glycolysis, is mediated by the GLUT (SLC2) family of integral membrane transporters (Mueckler and Thorens, 2013). GLUT1 (SLC2A1), one of the most well-studied members of the SLC2 family, exhibits a wide tissue distribution; cell surface expressio
-
br Experimental methods br Acknowledgments We thank
2022-02-28

Experimental methods Acknowledgments We thank all members of the Hermanson lab, especially Ana Teixeira, Shirin Ilkhanizadeh and Karolina Wallenborg, for assistance and discussions, Peter Löw for anti-synaptotagmin antibody, and Lars Björklund, Ole Isacson, Christer Höög, Claes Wahlestedt and
-
There are two ways to
2022-02-28

There are two ways to transport FFAs into cells. First by passive diffusion. Second as the putative long-chain fatty xanthine oxidase inhibitors transporters are proposed, CD36 the plasma membrane-associated fatty acid-binding protein (FABPpm) and fatty acid transport proteins (FATP) [11], where CD
-
Regulation of pancreatic and cell mass
2022-02-28

Regulation of pancreatic α and β cell mass has been extensively studied and hotly debated, due to potential therapeutic implications. Early claims of Angptl8 as “betatrophin” and Angptl4 as a regulator of glucagon secretion and α cell proliferation (Yi et al., 2013, Ben-Zvi et al., 2015) have not st
-
br Methods br Results br Discussion In this
2022-02-28

Methods Results Discussion In this series of studies we hypothesized that FHH-GHSRm1/Mcwi rats would, relative to their WT counterparts, exhibit a metabolic and behavioral phenotype reminiscent of GHSR−/− mice. Through the use of the GHSR−/− mouse, a great deal about the role of ghrelin sig
-
As with the GSIs there are
2022-02-28

As with the GSIs, there are again major concerns that GSM therapy in patients with symptomatic AD is almost certain to fail, unless the compound has additional mechanism of action not linked to Aβ that prove to beneficial [52]. Although Aβ1–42 or other longer Aβ peptides are critical for initiating
-
Introduction G quadruplexes are therapeutically important
2022-02-28

Introduction G-quadruplexes are therapeutically important non-canonical nucleic PNU 37883 hydrochloride receptor structures that are formed by a planar assembly of four guanines, termed G-tetrads (Fig. 1), in the guanine rich regions of genome [[1], [2], [3]]. As it is getting increasingly establi
8979 records 10/599 page Previous Next First page 上5页 678910 下5页 Last page